P505 Teletext 505 Oct27 21:11:17       ——————  ———————————————————  SHIRE GAINS AS US APPROVES KEY DRUG Shire Pharmaceuticals has finally won approval from US regulators for its kidney treatment Fosrenol. The Basingstoke-based company said it was another "milestone". Fosrenol helps patients with complications such as bone disorders and life-threatening heart and circulation problems. The drug should be available in US pharmacies by the end of the year. Shire shares rose on the announcement. ——————————————————————————————————————— Shire Pharma share price check 519 BACK A WINNER WITH RACING NEWS p550 Next news Shares Markets Racing